Abstract
BackgroundModerately complex NAATs that can provide fast, actionable results could reduce the burden of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections. The Xpert® CT/NG Assay is a recently FDA-cleared,...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
